Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Human Immunology Biosciences

Biotech & Life Sciences · San Francisco, United States · Founded 2021 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$1–2.5B
Latest valuation · 2026
Unlock exact value
Headcount
<100
Current team size
Unlock exact value

Investors

6 investors on Human Immunology Biosciences's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 3 investors entered at this stage
Monograph Capital
Jeito Capital
ARCH Venture Partners
Series B+ 3 investors entered at this stage
Arkin Capital
Alpha Wave Global
Viking Global Investors

Global footprint

Where Human Immunology Biosciences has talent and traffic

Web traffic by country
670 monthly visits
across markets
🇺🇸 United States104.5%
Top 1 markets shown

See Human Immunology Biosciences on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo